​​April policy updates include Intravenous Ketamine​​​

May 3, 2022

In April, Independence updated several policies. Recently published updates include:

  • 08.01.80: Intravenous Ketamine (Ketalar®) and Intranasal Esketamine (Spravato®). Effective date, 4/4/2022.
  • 01.00.12: Anesthesia Services for Epidural, Paravertebral Facet and Sacroiliac Joint Injections for Spinal Joint Management. Effective date, 4/11/2022.

To learn more about our Medical and Claim Payment Policy portal, visit our resource pag​e.

For important policy information related to COVID-19, visit the Commercial and Medicare Advantage News & Announcements sections of the portal.